Ana Villegas

2.4k total citations
138 papers, 1.5k citations indexed

About

Ana Villegas is a scholar working on Genetics, Hematology and Physiology. According to data from OpenAlex, Ana Villegas has authored 138 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 91 papers in Genetics, 76 papers in Hematology and 29 papers in Physiology. Recurrent topics in Ana Villegas's work include Hemoglobinopathies and Related Disorders (84 papers), Iron Metabolism and Disorders (46 papers) and Erythrocyte Function and Pathophysiology (27 papers). Ana Villegas is often cited by papers focused on Hemoglobinopathies and Related Disorders (84 papers), Iron Metabolism and Disorders (46 papers) and Erythrocyte Function and Pathophysiology (27 papers). Ana Villegas collaborates with scholars based in Spain, United States and Italy. Ana Villegas's co-authors include Tamara Lucas, Paloma Ropero, Fernando A. González, Kathryn Strom, Eduardo Anguita, Helena Ayyub, Beatriz Arrizabalaga, Douglas R. Higgs, D Espinós and Ángel F. Remacha and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and European Journal of Cancer.

In The Last Decade

Ana Villegas

129 papers receiving 1.5k citations

Peers

Ana Villegas

GENET

HEMAT

PHYSI

GENET

Kelly L. Bolton United States

Cristina Sanz Spain

Tom Bowen Canada

Helen Moore United States

Mary Petrou United Kingdom

Luan Eng Lie‐Injo United States

Nobuo Nara Japan

Lisa L. Smith United States

Beat M. Frey Switzerland

Kelly L. Bolton United States

Ana Villegas

250 ×0.3

GENET

374 ×0.5

HEMAT

384 ×1.2

52 ×0.2

PHYSI

301 ×1.4

GENET

Citations per year, relative to Ana Villegas Ana Villegas (= 1×) peers Kelly L. Bolton

Countries citing papers authored by Ana Villegas

Since Specialization

Citations

This map shows the geographic impact of Ana Villegas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Villegas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Villegas more than expected).

Fields of papers citing papers by Ana Villegas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Villegas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Villegas. The network helps show where Ana Villegas may publish in the future.

Co-authorship network of co-authors of Ana Villegas

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Villegas. A scholar is included among the top collaborators of Ana Villegas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Villegas. Ana Villegas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ropero, Paloma, et al.. (2025). Phenotype of sickle cell disease. Correlation of haplotypes and polymorphisms in cluster β, BCL11A, and HBS1L−MYB. Pilot study. Frontiers in Medicine. 12. 1347026–1347026.

Villegas, Ana, et al.. (2023). Near-term pregnant women in the Dominican Republic experience high rates of Group B Streptococcus rectovaginal colonization with virulent strains. SHILAP Revista de lepidopterología. 3(9). e0002281–e0002281. 2 indexed citations

Ropero, Paloma, et al.. (2021). Hb Maruchi [α165 (E14) Ala>Pro; HBA1: c.196G>C]: A new thalassemia hemoglobinopathy related to the alpha1 globin gene. Clinical Biochemistry. 92. 77–81. 1 indexed citations

González, Yolanda, et al.. (2020). Why is the novel Hb Miguel Servet visualised by CE-HPLC newborn and not by the CE-HPLC β-thalassaemia programme?. Journal of Clinical Pathology. 74(3). 198–201. 2 indexed citations

Ropero, Paloma, Fernando A. González, Jorge Martínez Nieto, et al.. (2019). C>A substitution in NT 46 of the 3’ UTR region (the α complex protected region) of the alpha-1 globin gene: a non-deletional mutation or polymorphism?. Journal of Clinical Pathology. 73(1). 14–16. 1 indexed citations

Cañón, Luis Ayala, et al.. (2019). Improving safety in blood transfusion using failure mode and effect analysis. Transfusion. 59(2). 516–523. 26 indexed citations

Nieto, Jorge Martínez, et al.. (2019). Characterization of deletional and non-deletional alpha globin variants in a large cohort from Spain between 2009 and 2014. Annals of Hematology. 98(7). 1537–1545. 6 indexed citations

Villegas, Ana, Fernando A. González, Jorge Martínez Nieto, et al.. (2016). Haemoglobinopathies that occur with decreased HbA ₂ levels: a gene mutation set involving the δ gene at a Spanish centre. Journal of Clinical Pathology. 70(1). 75–80. 4 indexed citations

Villegas, Ana, Beatriz Arrizabalaga, Santiago Bonanad, et al.. (2016). Consenso español para el diagnóstico y tratamiento de la hemoglobinuria paroxística nocturna. Medicina Clínica. 146(6). 278.e1–278.e7. 12 indexed citations

10.

Ojeda, Emilio, Rafael Forés, Miguel Pastrana, et al.. (2014). Paroxysmal nocturnal hemoglobinuria: a singleSpanish center's experience over the last 40 yr. European Journal Of Haematology. 93(4). 309–319. 26 indexed citations

11.

Nieto, Jorge Martínez, et al.. (2014). Heterozygosity for deletion of hypersensitive site 3 in the human locus control region has an unexpected minor effect on red cell phenotype. Journal of Human Genetics. 59(10). 585–587. 2 indexed citations

12.

Rubio, Montserrat López, Marta Morado, Emilio Ojeda, et al.. (2011). Tratamiento de la hemoglobinuria paroxística nocturna con eculizumab: experiencia en España. Medicina Clínica. 137(1). 8–13. 5 indexed citations

13.

Ropero, Paloma, et al.. (2007). Hemoglobina Fannin-Lubbock II [β111(G13)Val → Leu y β119(GH2)Gly → Asp]: descripción de 4 nuevos casos. Medicina Clínica. 129(10). 379–381. 4 indexed citations

14.

Ropero, Paloma, et al.. (2006). Frequency of the C282Y and H63D mutations of the hemochromatosis gene (HFE) in a cohort of 1,000 neonates in Madrid (Spain). Annals of Hematology. 85(5). 323–6. 9 indexed citations

15.

Chávez, Edgar, et al.. (2005). Una implementación completa del FQTrie. El Servicio de Difusión de la Creación Intelectual (National University of La Plata). 1 indexed citations

16.

Juncà, Jordi, et al.. (2002). Characterization of a new hemoglobin variant: Hb Badalona (β31[B13]Leu→Val). Annals of Hematology. 81(4). 179–181. 2 indexed citations

17.

Villegas, Ana, et al.. (1998). High incidence of the CD8/9 (+G) beta 0-thalassemia mutation in Spain.. PubMed. 83(12). 1066–8. 5 indexed citations

18.

Martı́n, Guillermo, et al.. (1990). Hb·Padova in a Spanish Family. Acta Haematologica. 84(1). 1–4. 1 indexed citations

19.

Villegas, Ana, et al.. (1986). Haemoglobin Presbyterian [Beta 108 (G 10) Asn→Lys] in a Spanish Family. Acta Haematologica. 76(2-3). 161–163. 7 indexed citations

20.

Wilson, J. B., et al.. (1986). The Identification of Five Rare β-Chain Abnormal Hemoglobins by High Performance Liquid Chromatographic Procedures. Hemoglobin. 10(1). 49–63. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact